![](/img/cover-not-exists.png)
Navitoclax (ABT-263) and bendamustine ± rituximab induce enhanced killing of non-Hodgkin's lymphoma tumours in vivo
S Ackler, MJ Mitten, J Chen, J Clarin, K Foster, S Jin, DC Phillips, S Schlessinger, B Wang, JD Leverson, ER BoghaertVolume:
167
Year:
2012
Language:
english
DOI:
10.1111/j.1476-5381.2012.02048.x
File:
PDF, 1.11 MB
english, 2012